USA - NASDAQ:ONTX - US68232V8019 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to ONTX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-10-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-14 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-06-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-25 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-21 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2022-03-01 | Ladenburg Thalmann | Initiate | Buy |
| 2021-05-18 | Guggenheim | Initiate | Buy |
9 analysts have analysed ONTX and the average price target is 8.5 USD. This implies a price increase of 754.01% is expected in the next year compared to the current price of 0.9953.
The consensus rating for ONCONOVA THERAPEUTICS INC (ONTX) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.